|

Obecabtagene autoleucel (obe-cel) Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • Autolus Limited2

Indications

  • Progressive Multiple Sclerosis1
  • Systemic Lupus Erythematosus1
  • Lupus1
  • Multiple Sclerosis1

Other1 trial

Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus
Phase 1

Redwood City, California1 trial

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Stanford University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.